An update on the treatment of vasovagal syncope

Hellenic Journal of Cardiology

Volumn 45, Issue 3, 2004, Pages 132-135

  Brignole, Michele ^a  

^a DEPARTMENT OF CARDIOLOGY   (Italy)

Author keywords

Vasovagal syncope

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIHYDROERGOTAMINE; DISOPYRAMIDE; ENALAPRIL; EPHEDRINE; ETILEFRINE; FLUDROCORTISONE; METOPROLOL; MIDODRINE; PAROXETINE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE;

BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; DRUG EFFECT; DRUG EFFICACY; HAND GRIP; HEART PACING; HIGH RISK POPULATION; HUMAN; HYPOTENSION; MECHANORECEPTOR; MUSCLE ISOMETRIC CONTRACTION; ORTHOSTATIC HYPOTENSION; PRESSORECEPTOR; RECURRENT DISEASE; SHORT SURVEY; SYMPATHETIC TONE; SYNCOPE; VASODILATATION;

EID: 30944457323     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (24)

1. Brignole M, Alboni P, Benditt D, et al: Guidelines on management (diagnosis and treatment) of syncope. Update 2004 - Executive summary and recommendations. Eur Heart J 2004; (in press).
2. Brignole M, Croci F, Menozzi C, et al: Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002; 40: 2054-2060.
3. Krediet CT, van Dijk N, Linzer M, et al: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002; 106: 1684-1689.
4. Brignole M, Menozzi C, Gianfranchi L, et al: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992; 70: 339-342.
5. Sheldon R, Rose S, Flanagan P, et al: Effects of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996; 78: 536-539.
6. Di Gerolamo E, Di Iorio C, Sabatini P, et al: Effects of different treatments vs no treatment on neurocardiogenic syncope. Cardiologia 1998; 43: 833-837.
7. Madrid A, Ortega I, Rebollo GJ, et al: Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in highly symptomatic population: a prospective double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001; 37: 554-557.
8. Ventura R, Maas R, Zeidler D, et al: A randomized and controlled pilot trial of b-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 2002; 25: 816-821.
9. Flevari P, Livanis E, Theodorakis G, et al: Vasovagal syncope: a prospective, randomized, cross-over evaluation of the effects of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. J Am Coll Cardiol 2002; 40: 499-504.
10. Raviele A, Brignole M, Sutton R, et al: Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999; 99: 1452-1457.
11. Ward CR, Gray JC, Gilroy JJ, et al: Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998; 79: 45-49.
12. Perez-Lugones A, Schweikert R, Pavia S, et al: Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001; 12: 935-938.
13. Jankovic J, Gilden JL, Hiner BC, et al: Neurogenic orthostatic hypotension: A double-blind placebo-controlled study with midodrine. Am J Med 1993; 95: 38-48.
14. Low PA, Gilden JL, Freeman R, et al: Efficacy of midrodrine vs placebo in neurogenic orthostatic hypotension. JAMA 1997; 13: 1046-1051.
15. Di Gerolamo E, Di Iorio C, Sabatini O, et al: Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 33: 1227-1230.
16. Takata T, Wasmund S, Smith M, et al: Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. PACE 2002; 106: 1500-1504.
17. Lee TM, Su SF, Chen MF, et al: Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 1996; 78: 480-482.
18. Biffi M, Boriani G, Sabbatani P, et al: Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart 1997; 77: 268-272.
19. Connolly SJ, Sheldon R, Roberts RS, et al: The North American vasovagal pacemaker study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16-20.
20. Sutton R, Brignole M, Menozzi C, et al: Dual-chamber pacing in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicentre randomized study. Circulation 2000; 102: 294-299.
21. Ammirati F, Colivicchi F, Santini M: Permanent Cardiac Pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 2001; 104: 52-57.
22. Connolly SJ, Sheldon R, Thorpe KE, et al: Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II). JAMA 2003; 289: 2224-2229.
23. Giada F, Raviele A, Menozzi C, et al: The vasovagal syncope and pacing trial (Synpace). A randomized placebo-controlled study of permanent pacing for treatment of recurrent vasovagal syncope. PACE 2003; 26: 1016 (abstract).
24. Moya A, Brignole M, Menozzi C, et al: Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001; 104: 1261-1267.